Atopic Dermatitis

Derm-Biome Announces Positive Preclinical Data in AD trials
September 16, 2021

Derm-Biome’s topical compounds have positive results in preclinical trial.

Dosing Starts in Tapinarof AD Trials
September 13, 2021

Dermavant has announced it has dosed the first patient in its phase 3 trial evaluating tapinarof cream for the treatment of moderate to severe atopic dermatitis.

Safety Study Evaluates Dupilumab in Pediatric Patients with Severe AD
September 07, 2021

A recent phase 3 trial investigated the safety of dupilumab as a treatment for severe atopic dermatitis in pediatric patients ages 6 to 11 years.